Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Intracerebral Hemorrhage
NCT06087965Phase 2Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Oct 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fingolimod in intracerebral hemorrhage (ICH), sponsored by Tangdu Hospital. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
fingolimod
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06087965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06087965.